- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06570005
Evaluating a Water Quality Assurance Fund Intervention in Ghana and Kenya
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Regular water quality monitoring by water suppliers is essential for maintaining adequate treatment processes and verifying safe water quality to protect public health. Yet, many small water suppliers are unable to conduct regular water quality tests due to financial, logistical, and capacity constraints. The goals of the Water Quality Assurance Fund program are to address these constraints by incentivizing established laboratories to extend their services to these smaller water systems and, in parallel, promote the use of water quality data for better water safety management.
The objective of this study is to evaluate the effects of a novel financial and capacity strengthening intervention (the 'Water Quality Assurance Fund' program) on water safety management in rural Ghana and Kenya. As part of the intervention, written legal agreements between water systems, centralized laboratories, and the organization facilitating the Assurance Fund will provide water systems with regular water quality testing and provide laboratories a guarantee of payments if water systems fail to pay for testing services on time. The Assurance Fund program will also deliver capacity strengthening, technical guidance, and community sensitization activities.
The investigators hypothesize the intervention will improve water system operator knowledge, chlorination practices, and water quality at the point of collection, as well as improve consumer satisfaction, awareness, and willingness-to-pay for water that is tested and treated. A secondary aim is to assess implementation challenges and enabling factors associated with the expansion of water testing services by existing professional water quality laboratories to rural water suppliers.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Valerie Bauza, PhD
- Phone Number: 4148011025
- Email: valerie@aquaya.org
Study Contact Backup
- Name: Caroline Delaire, PhD
- Email: caroline@aquaya.org
Study Locations
-
-
-
Accra, Ghana
- Recruiting
- The Aquaya Institute
-
Contact:
- Bashiru Yachori
- Phone Number: 233246884576
- Email: bashiru@aquaya.org
-
-
-
-
-
Nairobi, Kenya
- Recruiting
- The Aquaya Institute
-
Contact:
- Peace Musonge
- Phone Number: 32489116884
- Email: peace@aquaya.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Eligibility to receive the intervention was determined by water system criteria:
Inclusion Criteria:
- The district or county government was interested in participating in the Assurance Fund program and water systems within the district/county were accessible to a partner central laboratory that was able to provide water sample collection and testing services for a fee.
- Water systems were functional.
- Water systems were piped water systems (Kenya, Ghana) or mechanized boreholes with a single tapstand (Ghana).
- Water systems could afford regular water quality testing from the selected laboratory.
Exclusion Criteria:
- Water systems did not meet above inclusion criteria.
To be eligible to participate in household surveys, participants need to be at least 18 years of age and a customer of a eligible water system.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Assurance Fund Intervention Arm 1
In this study arm, intervention activities will start after initial baseline data collection.
|
|
|
Experimental: Assurance Fund Intervention Arm 2
The intervention activities are the same as those described in Arm 1.
However, in this study arm, the intervention activities will start 6 months later than those in Arm 1.
This arm will serve as a controlled comparison during those initial 6 months.
|
|
|
Experimental: Assurance Fund Intervention Arm 3
The intervention activities are the same as those described in Arm 1.
However, in this study arm, the intervention activities will start 12 months later than those in Arm 1.
This arm will serve as a controlled comparison during those initial 12 months.
|
|
|
Experimental: Non-randomized Arm
In Ghana only, there is a fourth study arm that will receive the intervention one month prior to Arm 1.
This group was non-randomly selected and will primarily serve to support qualitative lessons learned from the Assurance Fund program.
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adequate free chlorine residual in water at the point of collection
Time Frame: Baseline, 6-months, 12-months, 18-months, 24-months
|
Free chlorine residual in water at the point of collection above targeted levels of 0.2 mg/L.
|
Baseline, 6-months, 12-months, 18-months, 24-months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Detectable free chlorine residual in water at the point of collection
Time Frame: Baseline, 6-months, 12-months, 18-months, 24-months
|
Free chlorine residual in water at the point of collection above detectable levels of 0.1 mg/L.
|
Baseline, 6-months, 12-months, 18-months, 24-months
|
|
E. coli in water at the point of collection
Time Frame: Baseline, 6-months, 12-months, 18-months, 24-months
|
E. coli in water at point of collection (binary and categorical).
|
Baseline, 6-months, 12-months, 18-months, 24-months
|
|
Water system operator knowledge
Time Frame: Baseline, 12-months, 24-months
|
Water system operator knowledge related to water quality (score out of 32 points on a knowledge assessment).
|
Baseline, 12-months, 24-months
|
|
Consumer awareness
Time Frame: Baseline, 12-months, 24-months
|
Household respondent is aware enrolled water is tested or treated
|
Baseline, 12-months, 24-months
|
|
Consumer satisfaction
Time Frame: Baseline, 12-months, 24-months
|
Household respondent is satisfied with water supplier.
They will be considered satisfied if they report they are either very satisfied or somewhat satisfied with the water supplier.
They will be considered dissatisfied if they report they are either very dissatisfied or somewhat dissatisfied with the water supplier.
|
Baseline, 12-months, 24-months
|
|
Willingness-to-pay
Time Frame: Baseline, 12-months, 24-months
|
Stated willingness-to-pay for treated and tested water for standpipe and private tap users (% increase and absolute increase in local currency).
|
Baseline, 12-months, 24-months
|
|
Adequate free chlorine residual in household stored water
Time Frame: Baseline, 12-months, 24-months
|
Free chlorine residual in household stored water above targeted levels of 0.2 mg/L.
|
Baseline, 12-months, 24-months
|
|
Detectable free chlorine residual in household stored water
Time Frame: Baseline, 12-months, 24-months
|
Free chlorine residual in household stored water above detectable levels of 0.1 mg/L.
|
Baseline, 12-months, 24-months
|
|
E. coli in household stored water
Time Frame: Baseline, 12-months, 24-months
|
E. coli in household stored water (binary and categorical).
|
Baseline, 12-months, 24-months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Water system chlorination frequency
Time Frame: Baseline, 6-months, 12-months, 18-months, 24-months
|
Water system operator reports weekly chlorinating frequency.
|
Baseline, 6-months, 12-months, 18-months, 24-months
|
|
Water system revenue
Time Frame: Baseline, 6-months, 12-months, 18-months, 24-months
|
Revenue reported by water systems.
|
Baseline, 6-months, 12-months, 18-months, 24-months
|
|
Households use of enrolled water for drinking
Time Frame: Baseline, 12-months, 24-months
|
Households use of enrolled water for drinking (binary).
|
Baseline, 12-months, 24-months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Valerie Bauza, PhD, The Aquaya Institute
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- REAL-Water Assurance Fund
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Satisfaction
-
Shaukat Khanum Memorial Cancer Hospital & Research...CompletedSatisfaction, Patient | SatisfactionPakistan
-
Fu Jen Catholic UniversityRecruitingSatisfaction, PersonalTaiwan
-
Duke UniversityCompletedPatient Satisfaction | Clinician SatisfactionUnited States
-
Necmettin Erbakan UniversityGazi UniversityCompletedSatisfaction, Personal | KnowledgeTurkey (Türkiye)
-
University Hospital, BordeauxNot yet recruitingPregnancy | Telemedicine | Anesthesia | SatisfactionFrance
-
Necmettin Erbakan UniversityCompletedSatisfaction | Waste ManagementTurkey (Türkiye)
-
Ernesto LosavioItem OxygenNot yet recruitingSatisfaction | Usability | Acceptability | User Experience
-
Pamukkale UniversityCompletedFlexibility | Life Satisfaction | Body AwarenessTurkey (Türkiye)
-
Nanne KleefstraCompletedPatient Satisfaction | Doctor Satisfaction | Duration of ConsultationNetherlands
-
Brigham and Women's HospitalUniversity of Illinois at Urbana-Champaign; American Pistachio Growers; Quest... and other collaboratorsActive, not recruitingCognition | Life Satisfaction | Cardiometabolic Risk FactorsUnited States
Clinical Trials on Water Quality Assurance Fund
-
Dr. Derek ExnerUnknownMyocardial Infarction | Heart Failure | DeathCanada
-
National Cancer Institute (NCI)WithdrawnQuality of Care for Adolescent and Young Adult (AYA) Patients Living With Serious or Advanced CancerCancer | Patients Living With Stage IV or Recurrent CancerUnited States
-
Oregon Research InstituteStanford University; University of Texas at Austin; Trinity University, TexasCompletedEating DisorderUnited States
-
Hebrew SeniorLifeNational Institute of Nursing Research (NINR)Completed
-
International Centre for Diarrhoeal Disease Research...University of California, Berkeley; Emory University; University of California... and other collaboratorsActive, not recruiting
-
International Centre for Diarrhoeal Disease Research...University of California, Berkeley; Stanford UniversityRecruitingChild Development | Maternal DepressionBangladesh
-
Aalborg UniversityCompletedPoint-of-care Ultrasonography (POCUS)Denmark
-
Icahn School of Medicine at Mount SinaiPfizerCompletedFocus Group | Screening ToolUnited States
-
London School of Hygiene and Tropical MedicineIndian Institute of Technology KanpurCompletedDiarrhea | E.Coli Infections
-
University of Alabama at BirminghamCompleted